RU94030862A - Mixed inactivated vaccine against chlamydiosis, campilobacteriosis, salmonellosis and leptospirosis in sheep and goats - Google Patents

Mixed inactivated vaccine against chlamydiosis, campilobacteriosis, salmonellosis and leptospirosis in sheep and goats

Info

Publication number
RU94030862A
RU94030862A RU94030862/13A RU94030862A RU94030862A RU 94030862 A RU94030862 A RU 94030862A RU 94030862/13 A RU94030862/13 A RU 94030862/13A RU 94030862 A RU94030862 A RU 94030862A RU 94030862 A RU94030862 A RU 94030862A
Authority
RU
Russia
Prior art keywords
antigen
leptospira
salmonella
antigens
вгнк
Prior art date
Application number
RU94030862/13A
Other languages
Russian (ru)
Other versions
RU2086259C1 (en
Inventor
В.И. Белоусов
Ю.Д. Караваев
Ю.А. Малахов
М.А. Лучко
И.П. Иренков
А.К. Елисеев
В.М. Усольцев
Г.Л. Соболева
Original Assignee
Всероссийский научно-исследовательский и технологический институт биологической промышленности
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всероссийский научно-исследовательский и технологический институт биологической промышленности filed Critical Всероссийский научно-исследовательский и технологический институт биологической промышленности
Priority to RU94030862A priority Critical patent/RU2086259C1/en
Publication of RU94030862A publication Critical patent/RU94030862A/en
Application granted granted Critical
Publication of RU2086259C1 publication Critical patent/RU2086259C1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

FIELD: veterinary science. SUBSTANCE: mixed inactivated vaccine has the following components: leptospira antigen Grippotifoza "ВГНК"-1 3.8-4.27; leptospira antigen Tarassovi "ВГНК"-4 3.8-4.27; leptospira antigen Pomona "ВГНК"-6 3.8-4.27; leptospira antigen Seiro "ВГНК"-5 1.3-1.43; leptospira antigen Hargio 1.3-1.43; leptospira antigen Usoltzev or 2685 1.3-1.43; salmonella abortus ovi antigen 7.3-9.3; salmonella typhimurium antigen 1.0-2.5; salmonella dublin antigen 1.0-2.5; chlamydia psitacci (K-8) antigen 11-13; campilobacteria fetus subspecius intestinalis (N 30) antigen 0.88-1.4; formalin 0.2-0.4, and adjuvant - the rest. Vaccine provides simultaneous 100% protection of sheep and goats against leptospirosis, salmonellosis, chlamydiosis and campilobacteriosis and can be used for prophylaxis in animal husbandry. EFFECT: enhanced effectiveness of protection. 2 tbl

Claims (1)

Изобретение относится к ветеринарии и может быть использовано в животноводстве для профилактики у мелкого рогатого скота абортов инфекционной этиологии, вызываемых хламидиями, кампилобактериями, сальмонеллами, лептоспирами. Ассоциированная инактивированная вакцина содержит антиген лептоспир Гриппотифоза, антиген лептоспир Тарассови, антиген лептоспир Помона, антиген лептоспир Мейро, антиген лептоспир Харджио, антиген лептоспир Усольцев или 2685, антиген сальмонелла абортус овис, антиген сальмонелла тифимуриум, антиген сальмонелла дублин, антиген хламидиа пситакци (штамм К-8), антиген кампилобактерий фетус субспециес интестиналис N 30, формалин и адъювант при следующем соотношении компонентов, мас.%.: антиген лептоспир Гриппотифоза 3,8 - 4,27; антиген лептоспир Тарассови 3,8 - 4,27; антиген Помона 3,8 - 4,27; антигенлептоспир Сейро 1,3 - 1,43; антиген лептоспир Харджио 1,3 - 1,43; антиген лептоспир Усольцев 1,3 - 1,43; антиген сальмонелла абортус овис 7,3 - 9,3; антиген сальмонелла тифимуриум 1,0 - 2,5; антиген сальмонелла дублин 1,0 - 2,5; антиген хламидиа пситакци 11,0 - 13,0; антиген кампилобактерий фетус субспециес интестиналис 0,88 - 1,4; формалин 0,2 - 0,4; адъювант остальное. Вакцина обеспечивает одновременно 100%-ную защиту от лептоспирозов, сальмонеллезов, хламидиоза и кампилобактериоза у овец и коз.The invention relates to veterinary medicine and can be used in animal husbandry for the prevention in small cattle of abortions of infectious etiology caused by chlamydia, campylobacter, salmonella, leptospira. The associated inactivated vaccine contains the Leptospira antigen Grippotyphosis, the Tarassovi leptospira antigen, the Pomona antigen leptospira, the Meiro leptospira antigen, the Harjio antigen leptospira, the Usoltsev antigen or 2685, the salmonella antigens, Salmonella decibelma antigens, Salmonella antigen antigens, Salmonella 8), campylobacter fetus antigen subspecies intestinalis N 30, formalin and adjuvant in the following ratio of components, wt.%: Leptospira antigen Flu-typhoid 3.8 - 4.27; Leptospira antigen Tarassovi 3.8 - 4.27; Pomon antigen 3.8 - 4.27; antigenleptospira seiro 1.3 - 1.43; Leggospire antigen Hargio 1.3 - 1.43; Leptospira antigen Usoltsev 1.3 - 1.43; Salmonella antigen abortus ovis 7.3 - 9.3; Salmonella antigen typhimurium 1.0 - 2.5; salmonella antigen Dublin 1.0 - 2.5; chlamydia antigens psitacti 11.0 - 13.0; Campylobacter antigens fetus subspecies intestinalis 0.88 - 1.4; formalin 0.2 - 0.4; adjuvant rest. The vaccine simultaneously provides 100% protection against leptospirosis, salmonella, chlamydia and campylobacteriosis in sheep and goats.
RU94030862A 1994-08-03 1994-08-03 Mixed inactivated vaccine for control of chlamydiosis, campylobacteriosis, salmonellosis and leptospirosis in sheep and goats RU2086259C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94030862A RU2086259C1 (en) 1994-08-03 1994-08-03 Mixed inactivated vaccine for control of chlamydiosis, campylobacteriosis, salmonellosis and leptospirosis in sheep and goats

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94030862A RU2086259C1 (en) 1994-08-03 1994-08-03 Mixed inactivated vaccine for control of chlamydiosis, campylobacteriosis, salmonellosis and leptospirosis in sheep and goats

Publications (2)

Publication Number Publication Date
RU94030862A true RU94030862A (en) 1996-11-10
RU2086259C1 RU2086259C1 (en) 1997-08-10

Family

ID=20159877

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94030862A RU2086259C1 (en) 1994-08-03 1994-08-03 Mixed inactivated vaccine for control of chlamydiosis, campylobacteriosis, salmonellosis and leptospirosis in sheep and goats

Country Status (1)

Country Link
RU (1) RU2086259C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2991675B1 (en) * 2013-04-05 2019-07-24 The Governors of the University of Alberta Campylobacter vaccine
RU2644654C2 (en) * 2016-07-20 2018-02-13 Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины Method for producing hydroxide of aluminum oil theo-vaccine against campylobacteriosis

Also Published As

Publication number Publication date
RU2086259C1 (en) 1997-08-10

Similar Documents

Publication Publication Date Title
Albina et al. Immune responses in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV)
Salt et al. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission
HRP20050192B1 (en) Vaccine for respiratory and reproductive system infections in cattle
Bolin Control of bovine viral diarrhea infection by use of vaccination
PT759780E (en) MODIFIED VSRB IMPROVED VACCINE
Cole et al. Mycoplasma-induced arthritis
Hechinger et al. Single immunization with an inactivated vaccine protects sheep from Schmallenberg virus infection
Chiers et al. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins
US4110433A (en) Equine rhinopneumonitis virus
Ficken et al. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation
RU94030862A (en) Mixed inactivated vaccine against chlamydiosis, campilobacteriosis, salmonellosis and leptospirosis in sheep and goats
UY26450A1 (en) ATTENUATED AND SAFE VIRUSES FROM BOVINE VIRAL DIARRHEA FOR USE IN PREGNANT COWS.
Gökce et al. Sero-prevalence of contagious ecthyma in lambs and humans in Kars, Turkey
Fairbanks et al. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge
Sadi et al. Serologic survey of white-tailed deer on Anticosti Island, Quebec for bovine herpesvirus 1, bovine viral diarrhea, and parainfluenza 3
CA2114611A1 (en) Method of reversing immunosuppression in vaccines
Erickson et al. Evaluation of bovine respiratory syncytial virus (BRSV) and bovine herpesvirus (BHV) specific antibody responses between heterologous and homologous prime-boost vaccinated western Canadian beef calves
Durham et al. Serological studies of infectious bovine rhinotracheitis, parainfluenza 3, bovine viral diarrhea, and bovine respiratory syncytial viruses in calves following entry to a bull test station
YU65102A (en) In ovo protection against infectious bronchitis
Cerviño et al. Specific humoral response and effect on rectal temperature of two clostridial vaccines in lambs
HUP9700975A2 (en) Live attenuated rtx-producing bacteria of the family pasteurellaceae
Mikula et al. Dialyzable leukocyte extract used in the prevention of Salmonella infection in calves
Higgins et al. Studies of maternally-acquired antibodies in the foal to equine influenza A1 and A2, and equine rhinopneumonitis
Schuurman The serological response of adult cattle to vaccination with reduced dose Brucella abortus S19, a trial under Zambian conditions
Qureshi et al. Effect of levamisole hydrochloride on serum and colostral antibody titres against foot and mouth disease virus in vaccinated buffaloes (Bubalus bubalis)